Promedica Clinical Research Center Inc is categorized under Research and Development Laboratories in Boston, MA and active since 1996.
Promedica Clinical Research Center Inc was established in 1996, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Tricia Fabrizio at the company’s single location by writing to 77 Warren St, Boston, Massachusetts MA 02119 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Promedica Clinical Research Center Inc |
Contact Person: | Tricia Fabrizio |
Address: | 77 Warren St, Boston, Massachusetts 02119 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 1996 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Research and Development Laboratories |
SIC Code: | 8731 |
NAICS Code: | 541712 |
Share This Business: |
Promedica Clinical Research Center Inc was started in 1996 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Tricia Fabrizio for inquiries that concern Promedica Clinical Research Center Inc by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Promedica Clinical Research Center Inc can be found at the coordinates 42.327862,-71.083412 as well as the street address 77 Warren St in Boston, Massachusetts 02119.
For its online presence, you may visit Promedica Clinical Research Center Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.